Clearmind Medicine Inc. Current Derivative Financial Liabilities
Clearmind Medicine Inc. (CMND) had Current Derivative Financial Liabilities of $4.31 million as of 2024-07-31, per its 6-K filed 2024-09-16.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2024-09-16
- 2022-10-31: Current Derivative Financial Liabilities 290.57K CAD; Current Derivative Financial Liabilities as first filed 396.60K CAD.
CAD
| Period end | Current Derivative Financial Liabilities | Current Derivative Financial Liabilities as first filed |
|---|---|---|
| 2022-10-31 | 290.57K CAD 20-F/A · filed 2024-03-18 | 396.60K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2024-07-31 | $4.31M 6-K · filed 2024-09-16 |
| 2024-04-30 | $3.73M 6-K · filed 2024-06-13 |
| 2024-01-31 | $4.20M 6-K · filed 2024-03-19 |
| 2023-11-01 | $4.31M 6-K · filed 2024-09-16 |
| 2023-10-31 | $4.31M 6-K · filed 2024-09-16 |
| 2022-10-31 | $290.57K 20-F/A · filed 2024-03-18 |